Sign In
Get Clay Free →

Jeffrey B. Kindler

CEO, Centrexion Therapeutics

Jeff Kindler is a seasoned healthcare executive, investor, and advisor with over 30 years of experience in leadership roles at prominent companies like Pfizer, McDonald's, and General Electric.

He is an expert in pharmaceuticals, healthcare, retail, corporate legal matters, brand and franchise management, and crisis management.

Currently, Jeff Kindler serves as the CEO of Centrexion Corporation, a biotherapeutics company, and holds advisory positions at Blackstone and Artis Ventures.

He is actively involved in the healthcare sector as a principal in and advisor to various privately held firms and sponsors, and serves as the Global Chair of the GLG Institute, a premier executive learning community.

In addition to his corporate roles, Kindler contributes to the boards of several public and private healthcare companies, as well as not-for-profit institutions like Tufts University and Jazz at Lincoln Center.

Jeff Kindler holds a Bachelor's Degree, Summa Cum Laude from Tufts University and a Juris Doctor (J.D.), Magna Cum Laude from Harvard University.

His extensive career includes leadership roles such as Chairman and CEO at Pfizer, General Counsel at McDonald's Corporation, and VP of Litigation and Legal Policy at General Electric.

Kindler's professional journey also includes experiences as an Operating Partner at ARTIS Ventures, Executive Chairman at vTv Therapeutics LLC, and Fund Advisor at Israel Biotech Fund, among others.

He has a diverse legal background, having worked as a Partner at Williams & Connolly LLP, an Attorney at the Federal Communications Commission, and in clerkship roles at the Supreme Court of the United States and the United States Court of Appeals for the D.C. Circuit.